AI ASSISTANT
Ask DrugCentral
Explore drug properties, targets, and indications with answers grounded in DrugCentral.
Powered by DrugCentral + retrieval-augmented AIYour question
Ask in your own words. Each question is answered independently.
Explore sample questions
Select a question to fill the editor, then ask it or make it your own.
DrugCentral answer
Your answer will appear here. Open linked drug cards in a new tab to explore the source details.
About Ask DrugCentral
Ask DrugCentral helps you explore drug properties, biological targets, and indications using natural language. Sample questions offer starting points, and linked drug cards let you check the underlying records.
General architecture
- Ask a questionThe browser sends your question to the same-origin Django chat API.
- Retrieve and generateThe API forwards the question to the configured DrugCentral retrieval-augmented generation (RAG) service, which returns an AI-generated answer.
- Explore the answerThe app resolves cited drug-card names and displays the answer with links to drug records.
Using the assistant
Each request is independent; previous questions are not sent as conversation history. You can edit a sample before submitting, retry a failed request, or switch back to normal search. Drug links open in a new tab so your question and answer stay available.
Answers may contain mistakes or omit information. Verify details against DrugCentral records and original sources.
AI can make mistakes. Verify answers against the original sources before relying on them.
febuxostat 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | PK/Tox | Related Drugs | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| xanthine oxydase and xanthine dehydrogenase inhibitor | 1137 | 144060-53-7 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
A thiazole derivative and inhibitor of XANTHINE OXIDASE that is used for the treatment of HYPERURICEMIA in patients with chronic GOUT.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 80 | mg | O |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 2 | Benet LZ, Broccatelli F, Oprea TI |
| S (Water solubility) | 0.01 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
| EoM (Fraction excreted unchanged in urine) | 3 % | Benet LZ, Broccatelli F, Oprea TI |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 3.61 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| BA (Bioavailability) | 84 % |
Predicted pharmacokinetic/toxicological properties (PK-AZ):
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| mdck-mdr1-bcrp-efflux | MDCK-MDR1-BCRP efflux ratio | 7.621 | High | 1 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| rat-kpuu-brain | Rat brain Kpuu | 0.039 | % | High | 1 |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Feb. 26, 2015 | EMA | ||
| Feb. 13, 2009 | FDA | TAKEDA PHARMS USA | |
| Jan. 21, 2011 | PMDA | Teijin Pharma Limited |
FDA Adverse Event Reporting System (Female)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Enthesopathy | 324.34 | 16.11 | 111 | 21558 | 9293 | 90597485 |
| Renal impairment | 295.86 | 16.11 | 226 | 21443 | 105195 | 90501583 |
| Tongue disorder | 286.31 | 16.11 | 105 | 21564 | 10755 | 90596023 |
| Cardiac failure | 279.63 | 16.11 | 222 | 21447 | 109274 | 90497504 |
| Tenosynovitis | 276.99 | 16.11 | 111 | 21558 | 14456 | 90592322 |
| Blood parathyroid hormone decreased | 267.13 | 16.11 | 103 | 21566 | 12113 | 90594665 |
| Panniculitis | 257.12 | 16.11 | 105 | 21564 | 14353 | 90592425 |
| Red blood cell sedimentation rate | 246.19 | 16.11 | 76 | 21593 | 4582 | 90602196 |
| Skin necrosis | 237.82 | 16.11 | 104 | 21565 | 16837 | 90589941 |
| Granuloma skin | 236.91 | 16.11 | 91 | 21578 | 10589 | 90596189 |
| Drug eruption | 236.65 | 16.11 | 131 | 21538 | 35276 | 90571502 |
| Tendonitis | 217.73 | 16.11 | 105 | 21564 | 21267 | 90585511 |
| Rheumatoid nodule | 217.39 | 16.11 | 103 | 21566 | 20063 | 90586715 |
| Hypercalcaemia | 213.37 | 16.11 | 121 | 21548 | 34119 | 90572659 |
| Acute kidney injury | 205.47 | 16.11 | 313 | 21356 | 320074 | 90286704 |
| Ulcer | 172.64 | 16.11 | 104 | 21565 | 32778 | 90574000 |
| Aspartate aminotransferase increased | 172.11 | 16.11 | 164 | 21505 | 102773 | 90504005 |
| Basal cell carcinoma | 168.60 | 16.11 | 103 | 21566 | 33286 | 90573492 |
| Anaemia | 155.94 | 16.11 | 292 | 21377 | 352510 | 90254268 |
| Skin ulcer | 150.62 | 16.11 | 112 | 21557 | 49963 | 90556815 |
| Alanine aminotransferase increased | 147.64 | 16.11 | 161 | 21508 | 118177 | 90488601 |
| Alanine aminotransferase abnormal | 137.60 | 16.11 | 51 | 21618 | 5375 | 90601403 |
| Hyperkalaemia | 126.99 | 16.11 | 113 | 21556 | 64851 | 90541927 |
| Blood creatinine increased | 126.55 | 16.11 | 138 | 21531 | 101248 | 90505530 |
| Fear of injection | 112.14 | 16.11 | 50 | 21619 | 8465 | 90598313 |
| Platelet count decreased | 111.33 | 16.11 | 150 | 21519 | 136819 | 90469959 |
| Hepatic function abnormal | 107.74 | 16.11 | 89 | 21580 | 46199 | 90560579 |
| Rash pruritic | 102.74 | 16.11 | 112 | 21557 | 82102 | 90524676 |
| Neutrophil count decreased | 97.41 | 16.11 | 102 | 21567 | 71430 | 90535348 |
| Maternal exposure during pregnancy | 73.18 | 16.11 | 3 | 21666 | 360060 | 90246718 |
| Red blood cell sedimentation rate increased | 72.54 | 16.11 | 94 | 21575 | 82501 | 90524277 |
| Tumour lysis syndrome | 71.02 | 16.11 | 40 | 21629 | 11112 | 90595666 |
| Granuloma | 70.98 | 16.11 | 33 | 21636 | 6152 | 90600626 |
| Drug tolerance decreased | 69.02 | 16.11 | 59 | 21610 | 32071 | 90574707 |
| Systemic lupus erythematosus | 67.43 | 16.11 | 5 | 21664 | 361891 | 90244887 |
| Loss of personal independence in daily activities | 66.71 | 16.11 | 118 | 21551 | 135987 | 90470791 |
| Glossodynia | 64.33 | 16.11 | 3 | 21666 | 321776 | 90285002 |
| C-reactive protein abnormal | 61.83 | 16.11 | 110 | 21559 | 127319 | 90479459 |
| Cardiac failure acute | 58.15 | 16.11 | 36 | 21633 | 11893 | 90594885 |
| Erythema | 56.03 | 16.11 | 150 | 21519 | 229096 | 90377682 |
| Cardiac failure chronic | 55.25 | 16.11 | 27 | 21642 | 5619 | 90601159 |
| Joint injury | 54.44 | 16.11 | 52 | 21617 | 32612 | 90574166 |
| Rheumatoid lung | 53.73 | 16.11 | 24 | 21645 | 4079 | 90602699 |
| Wound | 51.60 | 16.11 | 6 | 21663 | 302974 | 90303804 |
| Discomfort | 50.49 | 16.11 | 4 | 21665 | 274331 | 90332447 |
| Drug ineffective | 49.68 | 16.11 | 168 | 21501 | 1384130 | 89222648 |
| Nephrogenic anaemia | 47.58 | 16.11 | 19 | 21650 | 2447 | 90604331 |
| Blood uric acid increased | 47.35 | 16.11 | 27 | 21642 | 7677 | 90599101 |
| Chronic kidney disease | 47.01 | 16.11 | 59 | 21610 | 50132 | 90556646 |
| Musculoskeletal disorder | 46.80 | 16.11 | 40 | 21629 | 21729 | 90585049 |
| C-reactive protein increased | 46.66 | 16.11 | 121 | 21548 | 181268 | 90425510 |
| Sinusitis | 45.19 | 16.11 | 13 | 21656 | 343075 | 90263703 |
| Lower respiratory tract infection | 45.18 | 16.11 | 4 | 21665 | 250655 | 90356123 |
| Swelling | 44.98 | 16.11 | 22 | 21647 | 419036 | 90187742 |
| Gout | 44.70 | 16.11 | 35 | 21634 | 16824 | 90589954 |
| Tubulointerstitial nephritis | 43.48 | 16.11 | 41 | 21628 | 25302 | 90581476 |
| Inflammation | 42.75 | 16.11 | 116 | 21553 | 178476 | 90428302 |
| Impaired healing | 41.50 | 16.11 | 4 | 21665 | 234195 | 90372583 |
| Duodenal ulcer perforation | 41.36 | 16.11 | 3 | 21666 | 221285 | 90385493 |
| Pericarditis | 39.96 | 16.11 | 8 | 21661 | 270143 | 90336635 |
| Cerebral infarction | 39.95 | 16.11 | 40 | 21629 | 26556 | 90580222 |
| Renal failure | 39.62 | 16.11 | 93 | 21576 | 130914 | 90475864 |
| Drug tolerance | 38.68 | 16.11 | 33 | 21636 | 17883 | 90588895 |
| Blood pressure systolic increased | 38.64 | 16.11 | 58 | 21611 | 58287 | 90548491 |
| Osteomyelitis | 36.63 | 16.11 | 39 | 21630 | 27807 | 90578971 |
| Cardiac failure congestive | 36.55 | 16.11 | 76 | 21593 | 98618 | 90508160 |
| White blood cell count decreased | 36.50 | 16.11 | 105 | 21564 | 167004 | 90439774 |
| Fibromyalgia | 35.32 | 16.11 | 4 | 21665 | 206265 | 90400513 |
| Pneumonia aspiration | 35 | 16.11 | 46 | 21623 | 40894 | 90565884 |
| Right ventricular failure | 34.74 | 16.11 | 32 | 21637 | 19173 | 90587605 |
| Cytokine release syndrome | 34.73 | 16.11 | 38 | 21631 | 27935 | 90578843 |
| Type 2 diabetes mellitus | 34.65 | 16.11 | 4 | 21665 | 203240 | 90403538 |
| Migraine | 34.41 | 16.11 | 3 | 21666 | 190389 | 90416389 |
| Paraesthesia | 33.86 | 16.11 | 9 | 21660 | 250317 | 90356461 |
| Anaemia macrocytic | 33.52 | 16.11 | 18 | 21651 | 4554 | 90602224 |
| Injury | 33.36 | 16.11 | 4 | 21665 | 197345 | 90409433 |
| Pulmonary arterial hypertension | 33.25 | 16.11 | 36 | 21633 | 26151 | 90580627 |
| Ill-defined disorder | 33.18 | 16.11 | 3 | 21666 | 184888 | 90421890 |
| Fatigue | 33.05 | 16.11 | 153 | 21516 | 1153870 | 89452908 |
| Melaena | 32.74 | 16.11 | 41 | 21628 | 34756 | 90572022 |
| Hyperuricaemia | 32.05 | 16.11 | 20 | 21649 | 6699 | 90600079 |
| Decreased appetite | 31.51 | 16.11 | 175 | 21494 | 376365 | 90230413 |
| Sleep disorder | 31.15 | 16.11 | 5 | 21664 | 198025 | 90408753 |
| Gastric disorder | 30.87 | 16.11 | 39 | 21630 | 33345 | 90573433 |
| Hepatic enzyme increased | 30.38 | 16.11 | 25 | 21644 | 360711 | 90246067 |
| Blood pressure decreased | 28.11 | 16.11 | 58 | 21611 | 74837 | 90531941 |
| Blister | 27.93 | 16.11 | 13 | 21656 | 254985 | 90351793 |
| Hypocalcaemia | 27.88 | 16.11 | 42 | 21627 | 42326 | 90564452 |
| Folate deficiency | 27.61 | 16.11 | 14 | 21655 | 3151 | 90603627 |
| Blood cholesterol increased | 27.16 | 16.11 | 8 | 21661 | 208004 | 90398774 |
| Wheezing | 26.29 | 16.11 | 12 | 21657 | 238068 | 90368710 |
| Disseminated intravascular coagulation | 26.29 | 16.11 | 29 | 21640 | 21509 | 90585269 |
| Dry mouth | 26.09 | 16.11 | 6 | 21663 | 184053 | 90422725 |
| Blood urea increased | 25.73 | 16.11 | 34 | 21635 | 30379 | 90576399 |
| Intentional product use issue | 25.44 | 16.11 | 10 | 21659 | 216882 | 90389896 |
| Atrial fibrillation | 25.44 | 16.11 | 80 | 21589 | 133531 | 90473247 |
| Depression | 25.10 | 16.11 | 21 | 21648 | 300580 | 90306198 |
| Interstitial lung disease | 25.03 | 16.11 | 56 | 21613 | 76349 | 90530429 |
| Coronavirus test positive | 24.87 | 16.11 | 9 | 21660 | 886 | 90605892 |
| Hypokalaemia | 24.50 | 16.11 | 78 | 21591 | 131038 | 90475740 |
| Renal disorder | 24.16 | 16.11 | 37 | 21632 | 37822 | 90568956 |
| Toxicity to various agents | 24.16 | 16.11 | 20 | 21649 | 287826 | 90318952 |
| Hypoalbuminaemia | 24.04 | 16.11 | 24 | 21645 | 15873 | 90590905 |
| Upper respiratory tract inflammation | 23.84 | 16.11 | 12 | 21657 | 2660 | 90604118 |
| Hypoaesthesia | 23.80 | 16.11 | 24 | 21645 | 314186 | 90292592 |
| Anaemia vitamin B12 deficiency | 23.43 | 16.11 | 8 | 21661 | 664 | 90606114 |
| Altered state of consciousness | 23.28 | 16.11 | 33 | 21636 | 31499 | 90575279 |
| Rhabdomyolysis | 23.25 | 16.11 | 43 | 21626 | 51213 | 90555565 |
| Gastrointestinal haemorrhage | 22.97 | 16.11 | 60 | 21609 | 90188 | 90516590 |
| Glomerular filtration rate decreased | 22.77 | 16.11 | 24 | 21645 | 16908 | 90589870 |
| Gastrointestinal disorder | 22.60 | 16.11 | 17 | 21652 | 256670 | 90350108 |
| Joint range of motion decreased | 22.31 | 16.11 | 3 | 21666 | 135640 | 90471138 |
| Lymphocyte count decreased | 22.01 | 16.11 | 34 | 21635 | 35016 | 90571762 |
| Anti-neutrophil cytoplasmic antibody positive vasculitis | 21.91 | 16.11 | 13 | 21656 | 3980 | 90602798 |
| Dyspepsia | 21.86 | 16.11 | 10 | 21659 | 198150 | 90408628 |
| Bile duct stone | 21.57 | 16.11 | 13 | 21656 | 4094 | 90602684 |
| Enanthema | 21.47 | 16.11 | 7 | 21662 | 503 | 90606275 |
| Pain | 21.44 | 16.11 | 145 | 21524 | 996196 | 89610582 |
| Therapeutic response decreased | 21.17 | 16.11 | 58 | 21611 | 89671 | 90517107 |
| Haemorrhage subcutaneous | 21.13 | 16.11 | 12 | 21657 | 3384 | 90603394 |
| Haemorrhoidal haemorrhage | 20.85 | 16.11 | 14 | 21655 | 5309 | 90601469 |
| Confusional state | 20.67 | 16.11 | 38 | 21631 | 386167 | 90220611 |
| Blood lactate dehydrogenase increased | 20.42 | 16.11 | 28 | 21641 | 25904 | 90580874 |
| Transfusion | 20.40 | 16.11 | 23 | 21646 | 17465 | 90589313 |
| Gait inability | 20.31 | 16.11 | 5 | 21664 | 146451 | 90460327 |
| Renal tubular necrosis | 20.23 | 16.11 | 21 | 21648 | 14534 | 90592244 |
| Dehydration | 20.16 | 16.11 | 96 | 21573 | 194351 | 90412427 |
| Urinary retention | 20.14 | 16.11 | 34 | 21635 | 37710 | 90569068 |
| Myoglobin blood increased | 20.07 | 16.11 | 9 | 21660 | 1543 | 90605235 |
| Haematochezia | 19.98 | 16.11 | 49 | 21620 | 70864 | 90535914 |
| Osteoarthritis | 19.90 | 16.11 | 11 | 21658 | 195719 | 90411059 |
| Systemic infection | 19.77 | 16.11 | 13 | 21656 | 4762 | 90602016 |
| Brain natriuretic peptide increased | 19.32 | 16.11 | 14 | 21655 | 5991 | 90600787 |
| Hyperferritinaemia | 19.25 | 16.11 | 6 | 21663 | 373 | 90606405 |
| Alopecia | 19.08 | 16.11 | 58 | 21611 | 495013 | 90111765 |
| Rash | 18.99 | 16.11 | 281 | 21388 | 795819 | 89810959 |
| Mesenteric vein thrombosis | 18.91 | 16.11 | 8 | 21661 | 1193 | 90605585 |
| Aplasia pure red cell | 18.77 | 16.11 | 13 | 21656 | 5181 | 90601597 |
| Shunt occlusion | 18.61 | 16.11 | 7 | 21662 | 768 | 90606010 |
| Bradycardia | 18.60 | 16.11 | 53 | 21616 | 83794 | 90522984 |
| Haematoma muscle | 18.56 | 16.11 | 9 | 21660 | 1841 | 90604937 |
| Concomitant disease aggravated | 18.55 | 16.11 | 18 | 21651 | 11500 | 90595278 |
| Product dose omission issue | 18.13 | 16.11 | 26 | 21643 | 291661 | 90315117 |
| Anxiety | 17.92 | 16.11 | 29 | 21640 | 309743 | 90297035 |
| Head injury | 17.85 | 16.11 | 29 | 21640 | 31159 | 90575619 |
| Iron deficiency anaemia | 17.81 | 16.11 | 25 | 21644 | 23637 | 90583141 |
| Nasal mucosal erosion | 17.81 | 16.11 | 4 | 21665 | 68 | 90606710 |
| Gastric ulcer | 17.76 | 16.11 | 27 | 21642 | 27421 | 90579357 |
| Nasopharyngitis | 17.68 | 16.11 | 45 | 21624 | 407059 | 90199719 |
| Psoriatic arthropathy | 17.68 | 16.11 | 104 | 21565 | 228231 | 90378547 |
| Pneumonia fungal | 17.36 | 16.11 | 14 | 21655 | 7017 | 90599761 |
| Injection site pain | 17.32 | 16.11 | 10 | 21659 | 173689 | 90433089 |
| Hepatic mass | 17.17 | 16.11 | 9 | 21660 | 2168 | 90604610 |
| Oedema peripheral | 17.17 | 16.11 | 113 | 21556 | 257802 | 90348976 |
| Chondrocalcinosis pyrophosphate | 16.50 | 16.11 | 7 | 21662 | 1051 | 90605727 |
| Memory impairment | 16.18 | 16.11 | 14 | 21655 | 197230 | 90409548 |
| Fixed eruption | 16.11 | 16.11 | 8 | 21661 | 1722 | 90605056 |
FDA Adverse Event Reporting System (Male)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Renal impairment | 284.42 | 13.06 | 409 | 36325 | 109819 | 42474782 |
| Cardiac failure | 199.65 | 13.06 | 342 | 36392 | 106514 | 42478087 |
| Tenosynovitis | 171.87 | 13.06 | 83 | 36651 | 4612 | 42579989 |
| Enthesopathy | 166.68 | 13.06 | 82 | 36652 | 4746 | 42579855 |
| Interstitial lung disease | 165.09 | 13.06 | 265 | 36469 | 78197 | 42506404 |
| Hepatic function abnormal | 160.92 | 13.06 | 210 | 36524 | 51357 | 42533244 |
| Tongue disorder | 132.88 | 13.06 | 73 | 36661 | 5310 | 42579291 |
| Acute kidney injury | 132.08 | 13.06 | 645 | 36089 | 366692 | 42217909 |
| Hyperkalaemia | 130.22 | 13.06 | 242 | 36492 | 80216 | 42504385 |
| Cerebral infarction | 119.82 | 13.06 | 141 | 36593 | 31028 | 42553573 |
| C-reactive protein abnormal | 107.85 | 13.06 | 78 | 36656 | 9183 | 42575418 |
| Platelet count decreased | 96.18 | 13.06 | 300 | 36434 | 138281 | 42446320 |
| Alanine aminotransferase abnormal | 95.13 | 13.06 | 57 | 36677 | 4887 | 42579714 |
| Tendonitis | 83.84 | 13.06 | 69 | 36665 | 9825 | 42574776 |
| Synovitis | 81.74 | 13.06 | 83 | 36651 | 15484 | 42569117 |
| Cardiac failure chronic | 81.45 | 13.06 | 67 | 36667 | 9534 | 42575067 |
| Tumour lysis syndrome | 81.19 | 13.06 | 98 | 36636 | 22133 | 42562468 |
| Drug abuse | 77.19 | 13.06 | 3 | 36731 | 104768 | 42479833 |
| Aspartate aminotransferase increased | 70.97 | 13.06 | 185 | 36549 | 76978 | 42507623 |
| Anaemia | 70.86 | 13.06 | 448 | 36286 | 279830 | 42304771 |
| Neutrophil count decreased | 69.93 | 13.06 | 163 | 36571 | 63252 | 42521349 |
| Blood creatinine increased | 67.12 | 13.06 | 228 | 36506 | 109775 | 42474826 |
| Drug ineffective | 67.09 | 13.06 | 298 | 36436 | 629899 | 41954702 |
| Respiratory tract haemorrhage | 64.24 | 13.06 | 29 | 36705 | 1380 | 42583221 |
| Gout | 63.40 | 13.06 | 98 | 36636 | 27957 | 42556644 |
| Drug eruption | 59.87 | 13.06 | 86 | 36648 | 22989 | 42561612 |
| Toxicity to various agents | 58.29 | 13.06 | 67 | 36667 | 229069 | 42355532 |
| Alanine aminotransferase increased | 55.46 | 13.06 | 185 | 36549 | 88221 | 42496380 |
| Red blood cell sedimentation rate | 54.93 | 13.06 | 24 | 36710 | 1056 | 42583545 |
| Granuloma skin | 52.99 | 13.06 | 24 | 36710 | 1151 | 42583450 |
| Cardiac failure acute | 52.91 | 13.06 | 62 | 36672 | 13571 | 42571030 |
| Gouty tophus | 52.85 | 13.06 | 15 | 36719 | 176 | 42584425 |
| Contraindicated product administered | 52.57 | 13.06 | 85 | 36649 | 25187 | 42559414 |
| Chronic kidney disease | 51.59 | 13.06 | 121 | 36613 | 47120 | 42537481 |
| Death | 51.11 | 13.06 | 221 | 36513 | 470964 | 42113637 |
| Blood parathyroid hormone decreased | 51.09 | 13.06 | 26 | 36708 | 1617 | 42582984 |
| Hyperuricaemia | 45.42 | 13.06 | 48 | 36686 | 9376 | 42575225 |
| Haemorrhage subcutaneous | 44.51 | 13.06 | 28 | 36706 | 2618 | 42581983 |
| Pemphigoid | 44.25 | 13.06 | 52 | 36682 | 11415 | 42573186 |
| Panniculitis | 44.19 | 13.06 | 26 | 36708 | 2155 | 42582446 |
| Fatigue | 43.24 | 13.06 | 211 | 36523 | 435430 | 42149171 |
| Hypocalcaemia | 40.54 | 13.06 | 84 | 36650 | 30089 | 42554512 |
| Concomitant disease aggravated | 39.94 | 13.06 | 38 | 36696 | 6548 | 42578053 |
| C-reactive protein increased | 39.84 | 13.06 | 133 | 36601 | 63427 | 42521174 |
| Cerebral haemorrhage | 39.52 | 13.06 | 97 | 36637 | 38869 | 42545732 |
| Off label use | 39.28 | 13.06 | 357 | 36377 | 637978 | 41946623 |
| Liver disorder | 38.43 | 13.06 | 97 | 36637 | 39547 | 42545054 |
| Rash | 38.04 | 13.06 | 385 | 36349 | 276569 | 42308032 |
| Psoriatic arthropathy | 36.51 | 13.06 | 72 | 36662 | 24895 | 42559706 |
| Pneumonia bacterial | 35.70 | 13.06 | 55 | 36679 | 15637 | 42568964 |
| Rubber sensitivity | 34.29 | 13.06 | 13 | 36721 | 395 | 42584206 |
| Lactic acidosis | 34.15 | 13.06 | 101 | 36633 | 45160 | 42539441 |
| Transformation to acute myeloid leukaemia | 32.95 | 13.06 | 17 | 36717 | 1088 | 42583513 |
| Hypokalaemia | 32.34 | 13.06 | 135 | 36599 | 71586 | 42513015 |
| Fulminant type 1 diabetes mellitus | 32.17 | 13.06 | 18 | 36716 | 1356 | 42583245 |
| Rheumatoid nodule | 32.10 | 13.06 | 24 | 36710 | 2971 | 42581630 |
| Congenital diaphragmatic anomaly | 31.16 | 13.06 | 7 | 36727 | 28 | 42584573 |
| Intentional overdose | 30.75 | 13.06 | 4 | 36730 | 51452 | 42533149 |
| Renal failure | 29.79 | 13.06 | 219 | 36515 | 143507 | 42441094 |
| Anxiety | 29.75 | 13.06 | 35 | 36699 | 118525 | 42466076 |
| Depression | 28.89 | 13.06 | 32 | 36702 | 111331 | 42473270 |
| Nephrogenic anaemia | 28.34 | 13.06 | 21 | 36713 | 2565 | 42582036 |
| Decreased appetite | 28.18 | 13.06 | 272 | 36462 | 192865 | 42391736 |
| Osteoma | 28.18 | 13.06 | 8 | 36726 | 94 | 42584507 |
| Corneal abscess | 27.80 | 13.06 | 6 | 36728 | 19 | 42584582 |
| Polycystic liver disease | 27.80 | 13.06 | 8 | 36726 | 99 | 42584502 |
| Orthostatic intolerance | 27.53 | 13.06 | 14 | 36720 | 869 | 42583732 |
| Stress | 27.50 | 13.06 | 3 | 36731 | 44209 | 42540392 |
| Glomerular filtration rate decreased | 27.43 | 13.06 | 50 | 36684 | 16301 | 42568300 |
| Product dose omission issue | 26.97 | 13.06 | 58 | 36676 | 154307 | 42430294 |
| Hyperhidrosis | 26.96 | 13.06 | 23 | 36711 | 90489 | 42494112 |
| Stevens-Johnson syndrome | 26.63 | 13.06 | 59 | 36675 | 22119 | 42562482 |
| Splenic necrosis | 26.57 | 13.06 | 8 | 36726 | 117 | 42584484 |
| Disseminated intravascular coagulation | 26.51 | 13.06 | 63 | 36671 | 24731 | 42559870 |
| Hyperkinetic heart syndrome | 26.38 | 13.06 | 8 | 36726 | 120 | 42584481 |
| Hypercalcaemia | 26.31 | 13.06 | 52 | 36682 | 18006 | 42566595 |
| Suicidal ideation | 25.94 | 13.06 | 5 | 36729 | 48156 | 42536445 |
| Gouty arthritis | 25.84 | 13.06 | 15 | 36719 | 1212 | 42583389 |
| Splenic cyst | 25.56 | 13.06 | 8 | 36726 | 134 | 42584467 |
| Cytomegalovirus nephritis | 25.51 | 13.06 | 8 | 36726 | 135 | 42584466 |
| Blood lactic acid | 25.43 | 13.06 | 10 | 36724 | 336 | 42584265 |
| Shock haemorrhagic | 25.16 | 13.06 | 48 | 36686 | 16194 | 42568407 |
| Haemoglobin urine present | 25.13 | 13.06 | 8 | 36726 | 142 | 42584459 |
| Skin necrosis | 24.97 | 13.06 | 29 | 36705 | 6285 | 42578316 |
| Activated partial thromboplastin time abnormal | 24.77 | 13.06 | 8 | 36726 | 149 | 42584452 |
| Altered state of consciousness | 24.70 | 13.06 | 68 | 36666 | 29191 | 42555410 |
| Adrenal insufficiency | 24.62 | 13.06 | 52 | 36682 | 18872 | 42565729 |
| Oedema peripheral | 24.12 | 13.06 | 200 | 36534 | 135876 | 42448725 |
| Product use in unapproved indication | 24.12 | 13.06 | 80 | 36654 | 184376 | 42400225 |
| Seizure | 23.92 | 13.06 | 42 | 36692 | 120519 | 42464082 |
| Asthenia | 23.91 | 13.06 | 143 | 36591 | 280650 | 42303951 |
| Hepatic enzyme increased | 23.70 | 13.06 | 90 | 36644 | 45694 | 42538907 |
| Diabetic nephropathy | 23.41 | 13.06 | 18 | 36716 | 2323 | 42582278 |
| Aggression | 22.93 | 13.06 | 5 | 36729 | 44158 | 42540443 |
| Drug ineffective for unapproved indication | 22.45 | 13.06 | 6 | 36728 | 46157 | 42538444 |
| Blood uric acid decreased | 22.39 | 13.06 | 10 | 36724 | 464 | 42584137 |
| Cerebral ventricular rupture | 22.24 | 13.06 | 8 | 36726 | 209 | 42584392 |
| Agitation | 22.19 | 13.06 | 14 | 36720 | 64300 | 42520301 |
| Cerebellar infarction | 22.15 | 13.06 | 17 | 36717 | 2188 | 42582413 |
| Drug-induced liver injury | 22.14 | 13.06 | 78 | 36656 | 38195 | 42546406 |
| General physical health deterioration | 22.04 | 13.06 | 213 | 36521 | 151033 | 42433568 |
| Thalamus haemorrhage | 21.78 | 13.06 | 13 | 36721 | 1106 | 42583495 |
| Procedural failure | 21.58 | 13.06 | 6 | 36728 | 65 | 42584536 |
| Erythema | 21.52 | 13.06 | 164 | 36570 | 108629 | 42475972 |
| Heat illness | 21.33 | 13.06 | 9 | 36725 | 363 | 42584238 |
| Arrhythmia | 20.66 | 13.06 | 79 | 36655 | 40238 | 42544363 |
| Suicide attempt | 20.59 | 13.06 | 7 | 36727 | 46093 | 42538508 |
| Brain natriuretic peptide increased | 20.21 | 13.06 | 27 | 36707 | 6743 | 42577858 |
| Urinary sediment present | 20.17 | 13.06 | 8 | 36726 | 275 | 42584326 |
| Erythema multiforme | 19.99 | 13.06 | 33 | 36701 | 9944 | 42574657 |
| Hypothyroidism | 19.97 | 13.06 | 67 | 36667 | 32017 | 42552584 |
| Gastric cancer | 19.79 | 13.06 | 27 | 36707 | 6876 | 42577725 |
| Dyspnoea paroxysmal nocturnal | 19.67 | 13.06 | 14 | 36720 | 1606 | 42582995 |
| Underdose | 19.63 | 13.06 | 44 | 36690 | 16622 | 42567979 |
| Mental status changes | 19.51 | 13.06 | 6 | 36728 | 42109 | 42542492 |
| Blood uric acid increased | 19.39 | 13.06 | 42 | 36692 | 15505 | 42569096 |
| Thrombotic cerebral infarction | 19.33 | 13.06 | 9 | 36725 | 460 | 42584141 |
| Lordosis | 18.50 | 13.06 | 8 | 36726 | 343 | 42584258 |
| Splenic lesion | 18.40 | 13.06 | 8 | 36726 | 348 | 42584253 |
| Post infection glomerulonephritis | 18.37 | 13.06 | 6 | 36728 | 116 | 42584485 |
| Disease progression | 18.30 | 13.06 | 63 | 36671 | 143593 | 42441008 |
| Melaena | 18.30 | 13.06 | 74 | 36660 | 38672 | 42545929 |
| Blood urea increased | 18.26 | 13.06 | 66 | 36668 | 32727 | 42551874 |
| Toxic skin eruption | 18.18 | 13.06 | 38 | 36696 | 13692 | 42570909 |
| Acute myeloid leukaemia | 18.07 | 13.06 | 51 | 36683 | 22205 | 42562396 |
| Upper respiratory tract inflammation | 17.71 | 13.06 | 14 | 36720 | 1882 | 42582719 |
| Nephrotic syndrome | 17.69 | 13.06 | 29 | 36705 | 8689 | 42575912 |
| Familial mediterranean fever | 17.59 | 13.06 | 5 | 36729 | 59 | 42584542 |
| Product prescribing error | 17.57 | 13.06 | 56 | 36678 | 26056 | 42558545 |
| Enterocolitis | 17.47 | 13.06 | 31 | 36703 | 9898 | 42574703 |
| Conjunctival ulcer | 17.44 | 13.06 | 5 | 36729 | 61 | 42584540 |
| White blood cell count decreased | 17.33 | 13.06 | 158 | 36576 | 110238 | 42474363 |
| Pleural effusion | 17.31 | 13.06 | 143 | 36591 | 97023 | 42487578 |
| Blood creatine phosphokinase increased | 17.30 | 13.06 | 85 | 36649 | 48253 | 42536348 |
| Somnolence | 17.23 | 13.06 | 63 | 36671 | 141042 | 42443559 |
| Infective spondylitis | 17.21 | 13.06 | 7 | 36727 | 257 | 42584344 |
| Pain | 17.18 | 13.06 | 132 | 36602 | 244716 | 42339885 |
| Intentional product use issue | 17.17 | 13.06 | 22 | 36712 | 71811 | 42512790 |
| Asthma | 17.17 | 13.06 | 17 | 36717 | 62297 | 42522304 |
| Haematochezia | 16.97 | 13.06 | 97 | 36637 | 58339 | 42526262 |
| Putamen haemorrhage | 16.74 | 13.06 | 7 | 36727 | 276 | 42584325 |
| Colon cancer | 16.74 | 13.06 | 30 | 36704 | 9651 | 42574950 |
| Hypopituitarism | 16.73 | 13.06 | 16 | 36718 | 2775 | 42581826 |
| Red blood cell abnormality | 16.64 | 13.06 | 8 | 36726 | 440 | 42584161 |
| Weight decreased | 16.59 | 13.06 | 108 | 36626 | 207840 | 42376761 |
| Low cardiac output syndrome | 16.50 | 13.06 | 9 | 36725 | 645 | 42583956 |
| Metastases to soft tissue | 16.45 | 13.06 | 8 | 36726 | 451 | 42584150 |
| Myelodysplastic syndrome | 16.43 | 13.06 | 50 | 36684 | 22695 | 42561906 |
| Tonsil cancer | 16.37 | 13.06 | 11 | 36723 | 1150 | 42583451 |
| Lymphocyte count decreased | 16.36 | 13.06 | 57 | 36677 | 27752 | 42556849 |
| Skin erosion | 16.25 | 13.06 | 16 | 36718 | 2875 | 42581726 |
| Dyslipidaemia | 16.05 | 13.06 | 29 | 36705 | 9389 | 42575212 |
| Small intestinal perforation | 16.02 | 13.06 | 16 | 36718 | 2925 | 42581676 |
| Loss of personal independence in daily activities | 16.01 | 13.06 | 85 | 36649 | 49731 | 42534870 |
| Cholangitis | 15.76 | 13.06 | 31 | 36703 | 10696 | 42573905 |
| International normalised ratio abnormal | 15.73 | 13.06 | 17 | 36717 | 3406 | 42581195 |
| Lower gastrointestinal haemorrhage | 15.59 | 13.06 | 31 | 36703 | 10777 | 42573824 |
| Oedema | 15.55 | 13.06 | 87 | 36647 | 51914 | 42532687 |
| Tachycardia | 15.25 | 13.06 | 41 | 36693 | 101046 | 42483555 |
| Orthopnoea | 15.25 | 13.06 | 21 | 36713 | 5396 | 42579205 |
| Lethargy | 15.11 | 13.06 | 11 | 36723 | 46879 | 42537722 |
| Rhabdomyolysis | 15.08 | 13.06 | 117 | 36617 | 77902 | 42506699 |
| Drug monitoring procedure incorrectly performed | 15.05 | 13.06 | 7 | 36727 | 357 | 42584244 |
| Cerebrovascular accident | 14.97 | 13.06 | 39 | 36695 | 97121 | 42487480 |
| Traumatic intracranial haematoma | 14.86 | 13.06 | 4 | 36730 | 38 | 42584563 |
| Physical deconditioning | 14.82 | 13.06 | 14 | 36720 | 2391 | 42582210 |
| Cardiac failure congestive | 14.72 | 13.06 | 125 | 36609 | 85477 | 42499124 |
| Prerenal failure | 14.68 | 13.06 | 14 | 36720 | 2419 | 42582182 |
| Hospitalisation | 14.64 | 13.06 | 26 | 36708 | 74304 | 42510297 |
| Sleep disorder | 14.59 | 13.06 | 12 | 36722 | 48083 | 42536518 |
| Prothrombin time ratio decreased | 14.57 | 13.06 | 8 | 36726 | 581 | 42584020 |
| Cardiac arrest | 14.56 | 13.06 | 47 | 36687 | 109273 | 42475328 |
| Musculoskeletal stiffness | 14.53 | 13.06 | 17 | 36717 | 57748 | 42526853 |
| Immune-mediated hepatic disorder | 14.29 | 13.06 | 14 | 36720 | 2500 | 42582101 |
| Thirst | 14.21 | 13.06 | 27 | 36707 | 9081 | 42575520 |
| Drug resistance | 13.97 | 13.06 | 6 | 36728 | 34242 | 42550359 |
| Puncture site infection | 13.94 | 13.06 | 4 | 36730 | 49 | 42584552 |
| Hypovolaemic shock | 13.92 | 13.06 | 26 | 36708 | 8633 | 42575968 |
| Periodontitis | 13.87 | 13.06 | 13 | 36721 | 2198 | 42582403 |
| Marasmus | 13.85 | 13.06 | 9 | 36725 | 890 | 42583711 |
| Haematocrit abnormal | 13.78 | 13.06 | 9 | 36725 | 897 | 42583704 |
| Pseudohyponatraemia | 13.78 | 13.06 | 5 | 36729 | 134 | 42584467 |
| Azotaemia | 13.75 | 13.06 | 21 | 36713 | 5923 | 42578678 |
| Intentional product misuse | 13.74 | 13.06 | 20 | 36714 | 61880 | 42522721 |
| Dehydration | 13.57 | 13.06 | 184 | 36550 | 141583 | 42443018 |
| Confusional state | 13.38 | 13.06 | 87 | 36647 | 167510 | 42417091 |
| Sputum discoloured | 13.36 | 13.06 | 28 | 36706 | 10104 | 42574497 |
| Hepatitis acute | 13.26 | 13.06 | 26 | 36708 | 8949 | 42575652 |
| Adverse drug reaction | 13.12 | 13.06 | 8 | 36726 | 37426 | 42547175 |
| Brain contusion | 13.09 | 13.06 | 9 | 36725 | 977 | 42583624 |
FDA Adverse Event Reporting System (Geriatric)
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Renal impairment | 615.78 | 12.39 | 605 | 54781 | 187840 | 110346073 |
| Cardiac failure | 472.16 | 12.39 | 524 | 54862 | 187102 | 110346811 |
| Enthesopathy | 408.00 | 12.39 | 173 | 55213 | 12305 | 110521608 |
| Acute kidney injury | 393.31 | 12.39 | 934 | 54452 | 634496 | 109899417 |
| Tenosynovitis | 366.92 | 12.39 | 174 | 55212 | 16109 | 110517804 |
| Tongue disorder | 341.31 | 12.39 | 159 | 55227 | 14139 | 110519774 |
| Hepatic function abnormal | 306.81 | 12.39 | 295 | 55091 | 89000 | 110444913 |
| Hyperkalaemia | 288.85 | 12.39 | 348 | 55038 | 135448 | 110398465 |
| Platelet count decreased | 265.21 | 12.39 | 440 | 54946 | 230003 | 110303910 |
| Tendonitis | 251.62 | 12.39 | 159 | 55227 | 25924 | 110507989 |
| Anaemia | 244.64 | 12.39 | 713 | 54673 | 546373 | 109987540 |
| Alanine aminotransferase abnormal | 232.75 | 12.39 | 107 | 55279 | 9227 | 110524686 |
| Interstitial lung disease | 228.58 | 12.39 | 314 | 55072 | 139020 | 110394893 |
| Drug eruption | 222.57 | 12.39 | 197 | 55189 | 53462 | 110480451 |
| Blood parathyroid hormone decreased | 221.10 | 12.39 | 115 | 55271 | 12974 | 110520939 |
| Red blood cell sedimentation rate | 220.70 | 12.39 | 87 | 55299 | 5127 | 110528786 |
| Aspartate aminotransferase increased | 215.05 | 12.39 | 328 | 55058 | 159608 | 110374305 |
| Panniculitis | 207.70 | 12.39 | 117 | 55269 | 15465 | 110518448 |
| Granuloma skin | 195.95 | 12.39 | 101 | 55285 | 11182 | 110522731 |
| Blood creatinine increased | 194.15 | 12.39 | 337 | 55049 | 182552 | 110351361 |
| Cerebral infarction | 188.92 | 12.39 | 177 | 55209 | 51661 | 110482252 |
| Neutrophil count decreased | 187.07 | 12.39 | 265 | 55121 | 120676 | 110413237 |
| Alanine aminotransferase increased | 176.29 | 12.39 | 324 | 55062 | 183449 | 110350464 |
| Skin necrosis | 175.32 | 12.39 | 118 | 55268 | 21394 | 110512519 |
| Tumour lysis syndrome | 173.40 | 12.39 | 135 | 55251 | 30666 | 110503247 |
| Rheumatoid nodule | 169.42 | 12.39 | 113 | 55273 | 20183 | 110513730 |
| Hypercalcaemia | 165.60 | 12.39 | 157 | 55229 | 46500 | 110487413 |
| Cardiac failure chronic | 137.73 | 12.39 | 86 | 55300 | 13725 | 110520188 |
| Cardiac failure acute | 115.28 | 12.39 | 96 | 55290 | 23982 | 110509931 |
| Maternal exposure during pregnancy | 113.54 | 12.39 | 3 | 55383 | 254880 | 110279033 |
| Chronic kidney disease | 111.81 | 12.39 | 163 | 55223 | 76128 | 110457785 |
| Ulcer | 109.21 | 12.39 | 121 | 55265 | 42995 | 110490918 |
| Drug ineffective | 107.80 | 12.39 | 396 | 54990 | 1520144 | 109013769 |
| Skin ulcer | 103.63 | 12.39 | 143 | 55243 | 63502 | 110470411 |
| Basal cell carcinoma | 99.40 | 12.39 | 118 | 55268 | 45152 | 110488761 |
| Systemic lupus erythematosus | 94.66 | 12.39 | 9 | 55377 | 254329 | 110279584 |
| Glossodynia | 93.99 | 12.39 | 4 | 55382 | 222000 | 110311913 |
| Gout | 93.27 | 12.39 | 103 | 55283 | 36463 | 110497450 |
| Fear of injection | 92.68 | 12.39 | 57 | 55329 | 8854 | 110525059 |
| Renal failure | 87.53 | 12.39 | 281 | 55105 | 226293 | 110307620 |
| Pemphigus | 87.22 | 12.39 | 5 | 55381 | 214565 | 110319348 |
| Hyperuricaemia | 86.83 | 12.39 | 66 | 55320 | 14465 | 110519448 |
| Fatigue | 83.19 | 12.39 | 321 | 55065 | 1215637 | 109318276 |
| Sinusitis | 77.41 | 12.39 | 26 | 55360 | 296662 | 110237251 |
| Hypocalcaemia | 76.64 | 12.39 | 126 | 55260 | 65240 | 110468673 |
| Cerebral haemorrhage | 75.85 | 12.39 | 125 | 55261 | 64843 | 110469070 |
| Toxicity to various agents | 75.03 | 12.39 | 78 | 55308 | 480477 | 110053436 |
| Fibromyalgia | 72.60 | 12.39 | 3 | 55383 | 170906 | 110363007 |
| Nephrogenic anaemia | 71.01 | 12.39 | 38 | 55348 | 4539 | 110529374 |
| Duodenal ulcer perforation | 69.67 | 12.39 | 5 | 55381 | 177695 | 110356218 |
| Respiratory tract haemorrhage | 69.42 | 12.39 | 29 | 55357 | 1985 | 110531928 |
| Pemphigoid | 67.42 | 12.39 | 65 | 55321 | 19642 | 110514271 |
| Pericarditis | 66.99 | 12.39 | 14 | 55372 | 219100 | 110314813 |
| Haemorrhage subcutaneous | 66.87 | 12.39 | 39 | 55347 | 5500 | 110528413 |
| Migraine | 66.80 | 12.39 | 5 | 55381 | 171647 | 110362266 |
| Helicobacter infection | 66.19 | 12.39 | 7 | 55379 | 181870 | 110352043 |
| Pain | 65.91 | 12.39 | 251 | 55135 | 954704 | 109579209 |
| Wound | 65.75 | 12.39 | 18 | 55368 | 234419 | 110299494 |
| Swelling | 65.64 | 12.39 | 48 | 55338 | 350993 | 110182920 |
| Depression | 65.27 | 12.39 | 39 | 55347 | 317296 | 110216617 |
| White blood cell count decreased | 64.99 | 12.39 | 257 | 55129 | 229133 | 110304780 |
| Rash pruritic | 64.45 | 12.39 | 148 | 55238 | 97921 | 110435992 |
| Lower respiratory tract infection | 63.94 | 12.39 | 21 | 55365 | 243085 | 110290828 |
| Impaired healing | 63.47 | 12.39 | 11 | 55375 | 196706 | 110337207 |
| Irritable bowel syndrome | 63.30 | 12.39 | 5 | 55381 | 164210 | 110369703 |
| Disseminated intravascular coagulation | 63.09 | 12.39 | 90 | 55296 | 41196 | 110492717 |
| Discomfort | 63.06 | 12.39 | 15 | 55371 | 214692 | 110319221 |
| Drug abuse | 61.65 | 12.39 | 8 | 55378 | 177403 | 110356510 |
| Decreased appetite | 60.07 | 12.39 | 426 | 54960 | 475420 | 110058493 |
| Ill-defined disorder | 59.83 | 12.39 | 5 | 55381 | 156848 | 110377065 |
| Injury | 59.24 | 12.39 | 9 | 55377 | 177256 | 110356657 |
| Cardiac failure congestive | 58.94 | 12.39 | 188 | 55198 | 150812 | 110383101 |
| Sleep disorder | 58.10 | 12.39 | 14 | 55372 | 198630 | 110335283 |
| Muscle injury | 58.09 | 12.39 | 3 | 55383 | 140804 | 110393109 |
| C-reactive protein abnormal | 57.65 | 12.39 | 169 | 55217 | 129526 | 110404387 |
| Dry mouth | 56.73 | 12.39 | 15 | 55371 | 199933 | 110333980 |
| Lactic acidosis | 56.56 | 12.39 | 136 | 55250 | 92675 | 110441238 |
| Concomitant disease aggravated | 56.03 | 12.39 | 54 | 55332 | 16310 | 110517603 |
| C-reactive protein increased | 55.29 | 12.39 | 236 | 55150 | 217683 | 110316230 |
| Pneumonia bacterial | 55.26 | 12.39 | 67 | 55319 | 26194 | 110507719 |
| Folliculitis | 54.92 | 12.39 | 9 | 55377 | 167644 | 110366269 |
| Granuloma | 54.28 | 12.39 | 42 | 55344 | 9448 | 110524465 |
| Anxiety | 53.84 | 12.39 | 56 | 55330 | 345022 | 110188891 |
| Rheumatoid lung | 53.81 | 12.39 | 31 | 55355 | 4273 | 110529640 |
| Rheumatoid factor positive | 53.70 | 12.39 | 3 | 55383 | 131637 | 110402276 |
| Melaena | 53.41 | 12.39 | 111 | 55275 | 68646 | 110465267 |
| Loss of personal independence in daily activities | 52.50 | 12.39 | 180 | 55206 | 149840 | 110384073 |
| Hypokalaemia | 51.33 | 12.39 | 204 | 55182 | 182244 | 110351669 |
| Type 2 diabetes mellitus | 50.84 | 12.39 | 13 | 55373 | 177219 | 110356694 |
| Gastrointestinal disorder | 50.78 | 12.39 | 29 | 55357 | 241923 | 110291990 |
| Joint swelling | 50.77 | 12.39 | 90 | 55296 | 442755 | 110091158 |
| Rhabdomyolysis | 50.77 | 12.39 | 154 | 55232 | 120247 | 110413666 |
| Altered state of consciousness | 50.71 | 12.39 | 98 | 55288 | 57528 | 110476385 |
| Blood urea increased | 50.25 | 12.39 | 95 | 55291 | 54862 | 110479051 |
| Intentional product use issue | 50.22 | 12.39 | 31 | 55355 | 247875 | 110286038 |
| Erythema | 49.84 | 12.39 | 282 | 55104 | 291165 | 110242748 |
| Cytokine release syndrome | 49.43 | 12.39 | 109 | 55277 | 70197 | 110463716 |
| Transformation to acute myeloid leukaemia | 49.39 | 12.39 | 21 | 55365 | 1502 | 110532411 |
| Intentional overdose | 48.47 | 12.39 | 5 | 55381 | 132496 | 110401417 |
| Atrial fibrillation | 47.35 | 12.39 | 234 | 55152 | 229408 | 110304505 |
| Asthma | 47.07 | 12.39 | 34 | 55352 | 250257 | 110283656 |
| Pleural effusion | 47.05 | 12.39 | 195 | 55191 | 177514 | 110356399 |
| Glomerular filtration rate decreased | 47.03 | 12.39 | 65 | 55321 | 28891 | 110505022 |
| Blood creatine phosphokinase increased | 46.60 | 12.39 | 109 | 55277 | 72968 | 110460945 |
| Bursitis | 44.80 | 12.39 | 6 | 55380 | 129912 | 110404001 |
| Haematochezia | 44.32 | 12.39 | 143 | 55243 | 115381 | 110418532 |
| Paraesthesia | 42.98 | 12.39 | 45 | 55341 | 276476 | 110257437 |
| Dehydration | 42.97 | 12.39 | 263 | 55123 | 279248 | 110254665 |
| Blood pressure decreased | 42.83 | 12.39 | 141 | 55245 | 114950 | 110418963 |
| Alopecia | 42.83 | 12.39 | 73 | 55313 | 364680 | 110169233 |
| Blood cholesterol increased | 41.95 | 12.39 | 20 | 55366 | 184765 | 110349148 |
| Pneumonia aspiration | 41.14 | 12.39 | 111 | 55275 | 81122 | 110452791 |
| Joint range of motion decreased | 41.13 | 12.39 | 6 | 55380 | 121826 | 110412087 |
| Blood lactate dehydrogenase increased | 40.98 | 12.39 | 77 | 55309 | 44257 | 110489656 |
| Upper respiratory tract inflammation | 40.53 | 12.39 | 26 | 55360 | 4345 | 110529568 |
| Lymphocyte count decreased | 40.52 | 12.39 | 89 | 55297 | 57154 | 110476759 |
| Hypoaesthesia | 39.60 | 12.39 | 60 | 55326 | 314163 | 110219750 |
| Stevens-Johnson syndrome | 39.13 | 12.39 | 78 | 55308 | 46823 | 110487090 |
| Gait inability | 39.12 | 12.39 | 10 | 55376 | 136366 | 110397547 |
| Oedema peripheral | 38.99 | 12.39 | 290 | 55096 | 328370 | 110205543 |
| Right ventricular failure | 38.80 | 12.39 | 56 | 55330 | 25898 | 110508015 |
| Acute myeloid leukaemia | 38.78 | 12.39 | 69 | 55317 | 38041 | 110495872 |
| Sleep disorder due to general medical condition, insomnia type | 38.60 | 12.39 | 4 | 55382 | 105639 | 110428274 |
| Wheezing | 38.04 | 12.39 | 43 | 55343 | 255187 | 110278726 |
| Diabetic nephropathy | 37.92 | 12.39 | 23 | 55363 | 3485 | 110530428 |
| Blister | 37.64 | 12.39 | 35 | 55351 | 227341 | 110306572 |
| Asthenia | 37.28 | 12.39 | 198 | 55188 | 688801 | 109845112 |
| Musculoskeletal disorder | 37.00 | 12.39 | 51 | 55335 | 22613 | 110511300 |
| Osteoarthritis | 36.76 | 12.39 | 23 | 55363 | 182600 | 110351313 |
| Erythema multiforme | 36.75 | 12.39 | 49 | 55337 | 21048 | 110512865 |
| Product use in unapproved indication | 36.64 | 12.39 | 109 | 55277 | 447268 | 110086645 |
| Brain natriuretic peptide increased | 36.52 | 12.39 | 36 | 55350 | 11173 | 110522740 |
| Confusional state | 36.39 | 12.39 | 117 | 55269 | 468563 | 110065350 |
| Nasopharyngitis | 36.09 | 12.39 | 91 | 55295 | 394270 | 110139643 |
| Off label use | 35.43 | 12.39 | 534 | 54852 | 1499651 | 109034262 |
| Renal disorder | 35.10 | 12.39 | 77 | 55309 | 49402 | 110484511 |
| Fulminant type 1 diabetes mellitus | 34.93 | 12.39 | 19 | 55367 | 2344 | 110531569 |
| Memory impairment | 34.18 | 12.39 | 29 | 55357 | 196915 | 110336998 |
| Arrhythmia | 34.16 | 12.39 | 94 | 55292 | 69481 | 110464432 |
| Stress | 33.74 | 12.39 | 6 | 55380 | 105342 | 110428571 |
| Injection site pain | 33.66 | 12.39 | 24 | 55362 | 177898 | 110356015 |
| Nephrotic syndrome | 33.62 | 12.39 | 38 | 55348 | 13793 | 110520120 |
| Aplasia pure red cell | 33.53 | 12.39 | 32 | 55354 | 9546 | 110524367 |
| Obesity | 33.11 | 12.39 | 8 | 55378 | 113343 | 110420570 |
| Colon cancer | 33.06 | 12.39 | 41 | 55345 | 16402 | 110517511 |
| Blood uric acid increased | 32.99 | 12.39 | 47 | 55339 | 21482 | 110512431 |
| Drug ineffective for unapproved indication | 32.62 | 12.39 | 6 | 55380 | 102832 | 110431081 |
| Thalamus haemorrhage | 32.43 | 12.39 | 17 | 55369 | 1947 | 110531966 |
| Drug tolerance decreased | 32.15 | 12.39 | 53 | 55333 | 27487 | 110506426 |
| Product dose omission issue | 32.03 | 12.39 | 71 | 55315 | 321711 | 110212202 |
| Hyperhidrosis | 31.99 | 12.39 | 28 | 55358 | 187270 | 110346643 |
| Pulmonary arterial hypertension | 31.91 | 12.39 | 58 | 55328 | 32510 | 110501403 |
| Adverse drug reaction | 31.73 | 12.39 | 7 | 55379 | 105552 | 110428361 |
| Cholangitis | 31.67 | 12.39 | 40 | 55346 | 16295 | 110517618 |
| Joint injury | 31.56 | 12.39 | 65 | 55321 | 39929 | 110493984 |
| Hypoalbuminaemia | 31.49 | 12.39 | 54 | 55332 | 28920 | 110504993 |
| Enterocolitis | 31.47 | 12.39 | 43 | 55343 | 18906 | 110515007 |
| Tubulointerstitial nephritis | 31.42 | 12.39 | 78 | 55308 | 54206 | 110479707 |
| Osteoma | 31.39 | 12.39 | 8 | 55378 | 109 | 110533804 |
| Febrile neutropenia | 31.27 | 12.39 | 268 | 55118 | 316499 | 110217414 |
| Pneumonia | 31.24 | 12.39 | 614 | 54772 | 876100 | 109657813 |
| Shock haemorrhagic | 31.23 | 12.39 | 52 | 55334 | 27195 | 110506718 |
| Peripheral venous disease | 31.22 | 12.39 | 3 | 55383 | 84114 | 110449799 |
| Drug tolerance | 31.19 | 12.39 | 40 | 55346 | 16545 | 110517368 |
| Gouty tophus | 31.06 | 12.39 | 11 | 55375 | 480 | 110533433 |
| Orthostatic intolerance | 31.05 | 12.39 | 17 | 55369 | 2124 | 110531789 |
| Hepatocellular carcinoma | 30.84 | 12.39 | 31 | 55355 | 9849 | 110524064 |
| Physical deconditioning | 30.25 | 12.39 | 20 | 55366 | 3517 | 110530396 |
| Dyspepsia | 29.75 | 12.39 | 31 | 55355 | 190934 | 110342979 |
| Hyperkinetic heart syndrome | 29.53 | 12.39 | 8 | 55378 | 140 | 110533773 |
| Osteomyelitis | 29.49 | 12.39 | 60 | 55326 | 36540 | 110497373 |
| Pyrexia | 29.33 | 12.39 | 621 | 54765 | 897644 | 109636269 |
| Suicidal ideation | 28.71 | 12.39 | 6 | 55380 | 93931 | 110439982 |
| Azotaemia | 28.51 | 12.39 | 30 | 55356 | 10055 | 110523858 |
| Cytomegalovirus nephritis | 28.38 | 12.39 | 8 | 55378 | 163 | 110533750 |
| Night sweats | 28.19 | 12.39 | 16 | 55370 | 133967 | 110399946 |
| Polycystic liver disease | 27.89 | 12.39 | 8 | 55378 | 174 | 110533739 |
| Wound infection | 27.81 | 12.39 | 7 | 55379 | 96458 | 110437455 |
| Cerebral ventricular rupture | 27.62 | 12.39 | 10 | 55376 | 465 | 110533448 |
| Blood lactic acid | 27.56 | 12.39 | 10 | 55376 | 468 | 110533445 |
| Splenic necrosis | 27.34 | 12.39 | 8 | 55378 | 187 | 110533726 |
| Suicide attempt | 27.05 | 12.39 | 9 | 55377 | 103385 | 110430528 |
| Embolic stroke | 26.50 | 12.39 | 27 | 55359 | 8716 | 110525197 |
| Gastric cancer | 26.34 | 12.39 | 30 | 55356 | 10978 | 110522935 |
| Arthropathy | 25.79 | 12.39 | 67 | 55319 | 287455 | 110246458 |
| Vomiting | 25.06 | 12.39 | 314 | 55072 | 910361 | 109623552 |
| Injection site reaction | 24.66 | 12.39 | 7 | 55379 | 89063 | 110444850 |
| Sedation | 24.55 | 12.39 | 3 | 55383 | 69680 | 110464233 |
| Corneal abscess | 24.40 | 12.39 | 6 | 55380 | 70 | 110533843 |
| Plasma cell myeloma | 24.21 | 12.39 | 78 | 55308 | 62858 | 110471055 |
| Splenic cyst | 24.08 | 12.39 | 8 | 55378 | 287 | 110533626 |
| Product prescribing error | 23.87 | 12.39 | 68 | 55318 | 51263 | 110482650 |
| Gouty arthritis | 23.59 | 12.39 | 13 | 55373 | 1646 | 110532267 |
| Weight increased | 23.56 | 12.39 | 119 | 55267 | 419525 | 110114388 |
| Red blood cell sedimentation rate increased | 23.18 | 12.39 | 89 | 55297 | 78213 | 110455700 |
| Shunt occlusion | 23.03 | 12.39 | 13 | 55373 | 1724 | 110532189 |
| Musculoskeletal pain | 23.00 | 12.39 | 35 | 55351 | 182988 | 110350925 |
| Infective spondylitis | 22.85 | 12.39 | 9 | 55377 | 529 | 110533384 |
| Cerebellar infarction | 22.80 | 12.39 | 18 | 55368 | 4169 | 110529744 |
| Putamen haemorrhage | 22.74 | 12.39 | 9 | 55377 | 536 | 110533377 |
| Thrombotic cerebral infarction | 22.65 | 12.39 | 10 | 55376 | 784 | 110533129 |
| Psoriasis | 22.63 | 12.39 | 22 | 55364 | 139971 | 110393942 |
| Influenza like illness | 22.60 | 12.39 | 8 | 55378 | 88404 | 110445509 |
| Pain in extremity | 22.58 | 12.39 | 147 | 55239 | 486971 | 110046942 |
| Pancreatitis acute | 22.56 | 12.39 | 74 | 55312 | 60200 | 110473713 |
| Adrenal insufficiency | 22.55 | 12.39 | 59 | 55327 | 42331 | 110491582 |
| Low cardiac output syndrome | 22.43 | 12.39 | 11 | 55375 | 1095 | 110532818 |
| Activated partial thromboplastin time abnormal | 22.14 | 12.39 | 8 | 55378 | 370 | 110533543 |
| Sudden death | 22.09 | 12.39 | 42 | 55344 | 24353 | 110509560 |
| Blood uric acid decreased | 22.06 | 12.39 | 12 | 55374 | 1481 | 110532432 |
| Incorrect route of product administration | 21.98 | 12.39 | 3 | 55383 | 64058 | 110469855 |
| Liver disorder | 21.94 | 12.39 | 134 | 55252 | 142109 | 110391804 |
| Gait disturbance | 21.89 | 12.39 | 69 | 55317 | 278139 | 110255774 |
| Enteritis infectious | 21.81 | 12.39 | 17 | 55369 | 3865 | 110530048 |
| Prerenal failure | 21.80 | 12.39 | 18 | 55368 | 4441 | 110529472 |
| Product quality issue | 21.54 | 12.39 | 6 | 55380 | 77293 | 110456620 |
| Gastric disorder | 21.53 | 12.39 | 50 | 55336 | 33307 | 110500606 |
| Ear infection | 21.38 | 12.39 | 3 | 55383 | 62729 | 110471184 |
| Pulmonary alveolar haemorrhage | 21.17 | 12.39 | 37 | 55349 | 20113 | 110513800 |
| Lung disorder | 21.14 | 12.39 | 36 | 55350 | 180011 | 110353902 |
| Gastrooesophageal reflux disease | 21.12 | 12.39 | 36 | 55350 | 179940 | 110353973 |
| Dyspnoea paroxysmal nocturnal | 21.04 | 12.39 | 14 | 55372 | 2488 | 110531425 |
| Drug titration error | 20.96 | 12.39 | 12 | 55374 | 1635 | 110532278 |
| Gamma-glutamyltransferase increased | 20.94 | 12.39 | 73 | 55313 | 61236 | 110472677 |
| Rash | 20.77 | 12.39 | 548 | 54838 | 820416 | 109713497 |
| Subdural haematoma | 20.70 | 12.39 | 52 | 55334 | 36402 | 110497511 |
| Coronavirus test positive | 20.69 | 12.39 | 11 | 55375 | 1296 | 110532617 |
| Arthralgia | 20.62 | 12.39 | 271 | 55115 | 779361 | 109754552 |
| Urinary retention | 20.46 | 12.39 | 79 | 55307 | 69604 | 110464309 |
| Thirst | 20.43 | 12.39 | 38 | 55348 | 21669 | 110512244 |
| Lordosis | 20.39 | 12.39 | 8 | 55378 | 465 | 110533448 |
| Neck pain | 20.31 | 12.39 | 19 | 55367 | 123111 | 110410802 |
| Seizure | 20.25 | 12.39 | 51 | 55335 | 221134 | 110312779 |
| Aortic dissection | 20.22 | 12.39 | 18 | 55368 | 4915 | 110528998 |
| Post infection glomerulonephritis | 20.05 | 12.39 | 6 | 55380 | 152 | 110533761 |
| Small intestinal perforation | 20.02 | 12.39 | 17 | 55369 | 4359 | 110529554 |
| Procedural failure | 19.94 | 12.39 | 6 | 55380 | 155 | 110533758 |
| Cytomegalovirus enterocolitis | 19.76 | 12.39 | 13 | 55373 | 2268 | 110531645 |
| Hypovolaemic shock | 19.69 | 12.39 | 30 | 55356 | 14553 | 110519360 |
| Spinal compression fracture | 19.62 | 12.39 | 34 | 55352 | 18358 | 110515555 |
| Drug monitoring procedure incorrectly performed | 19.59 | 12.39 | 9 | 55377 | 774 | 110533139 |
| Epistaxis | 19.59 | 12.39 | 122 | 55264 | 130250 | 110403663 |
| Gastrointestinal haemorrhage | 19.57 | 12.39 | 146 | 55240 | 165372 | 110368541 |
| Heat illness | 19.50 | 12.39 | 9 | 55377 | 783 | 110533130 |
| Lower gastrointestinal haemorrhage | 19.49 | 12.39 | 34 | 55352 | 18452 | 110515461 |
| Hepatotoxicity | 19.47 | 12.39 | 4 | 55382 | 63396 | 110470517 |
| Anaemia macrocytic | 19.36 | 12.39 | 21 | 55365 | 7282 | 110526631 |
| Haemoglobin decreased | 19.31 | 12.39 | 200 | 55186 | 248527 | 110285386 |
| Chest pain | 19.31 | 12.39 | 110 | 55276 | 376265 | 110157648 |
| Pneumocystis jirovecii pneumonia | 19.28 | 12.39 | 56 | 55330 | 42679 | 110491234 |
| Nail disorder | 19.21 | 12.39 | 3 | 55383 | 57932 | 110475981 |
| Abdominal discomfort | 19.20 | 12.39 | 117 | 55269 | 393741 | 110140172 |
| Intentional product misuse | 19.14 | 12.39 | 23 | 55363 | 132881 | 110401032 |
| Hepatitis acute | 19.12 | 12.39 | 34 | 55352 | 18732 | 110515181 |
| Rubber sensitivity | 19.07 | 12.39 | 13 | 55373 | 2405 | 110531508 |
| Conjunctival ulcer | 18.82 | 12.39 | 5 | 55381 | 81 | 110533832 |
| Myelodysplastic syndrome | 18.75 | 12.39 | 51 | 55335 | 37433 | 110496480 |
| Constipation | 18.74 | 12.39 | 267 | 55119 | 357519 | 110176394 |
| Blood pressure fluctuation | 18.74 | 12.39 | 7 | 55379 | 74817 | 110459096 |
| Tachycardia | 18.69 | 12.39 | 55 | 55331 | 226590 | 110307323 |
| General physical health deterioration | 18.68 | 12.39 | 308 | 55078 | 424987 | 110108926 |
| Myelosuppression | 18.62 | 12.39 | 95 | 55291 | 94245 | 110439668 |
| Toxic skin eruption | 18.59 | 12.39 | 42 | 55344 | 27473 | 110506440 |
| Concomitant disease progression | 18.55 | 12.39 | 15 | 55371 | 3595 | 110530318 |
| Illness | 18.48 | 12.39 | 9 | 55377 | 82162 | 110451751 |
| Bile duct stone | 18.30 | 12.39 | 19 | 55367 | 6270 | 110527643 |
| Orthopnoea | 18.29 | 12.39 | 25 | 55361 | 10996 | 110522917 |
| Splenic lesion | 18.12 | 12.39 | 8 | 55378 | 627 | 110533286 |
| Marasmus | 18.05 | 12.39 | 11 | 55375 | 1680 | 110532233 |
| Tonsil cancer | 17.93 | 12.39 | 10 | 55376 | 1296 | 110532617 |
| Hypercreatininaemia | 17.91 | 12.39 | 10 | 55376 | 1299 | 110532614 |
| Folate deficiency | 17.81 | 12.39 | 16 | 55370 | 4422 | 110529491 |
| Hypothyroidism | 17.74 | 12.39 | 78 | 55308 | 72821 | 110461092 |
| Cerebellar haemorrhage | 17.68 | 12.39 | 14 | 55372 | 3257 | 110530656 |
| Mental status changes | 17.64 | 12.39 | 8 | 55378 | 76114 | 110457799 |
| Prostatic specific antigen abnormal | 17.61 | 12.39 | 8 | 55378 | 671 | 110533242 |
| Systemic infection | 17.40 | 12.39 | 23 | 55363 | 9796 | 110524117 |
| Frequent bowel movements | 17.35 | 12.39 | 7 | 55379 | 71383 | 110462530 |
| Dyspnoea exertional | 17.31 | 12.39 | 100 | 55286 | 103960 | 110429953 |
| Cardiac amyloidosis | 17.20 | 12.39 | 13 | 55373 | 2824 | 110531089 |
| Metastases to soft tissue | 17.17 | 12.39 | 8 | 55378 | 711 | 110533202 |
| Renal ischaemia | 17.17 | 12.39 | 12 | 55374 | 2311 | 110531602 |
| Peritonitis | 16.95 | 12.39 | 45 | 55341 | 32562 | 110501351 |
| Haematoma muscle | 16.92 | 12.39 | 15 | 55371 | 4075 | 110529838 |
| Agitation | 16.89 | 12.39 | 19 | 55367 | 113032 | 110420881 |
| Iron deficiency anaemia | 16.86 | 12.39 | 44 | 55342 | 31515 | 110502398 |
| Sciatica | 16.78 | 12.39 | 13 | 55373 | 92386 | 110441527 |
| Cardiac dysfunction | 16.68 | 12.39 | 18 | 55368 | 6205 | 110527708 |
| Sleep disorder due to a general medical condition | 16.61 | 12.39 | 3 | 55383 | 52109 | 110481804 |
| Traumatic intracranial haematoma | 16.48 | 12.39 | 4 | 55382 | 44 | 110533869 |
| Enanthema | 16.44 | 12.39 | 9 | 55377 | 1125 | 110532788 |
| Dyslipidaemia | 16.36 | 12.39 | 29 | 55357 | 15936 | 110517977 |
| Haemoptysis | 16.35 | 12.39 | 75 | 55311 | 71279 | 110462634 |
| Henoch-Schonlein purpura | 16.31 | 12.39 | 14 | 55372 | 3643 | 110530270 |
| Weight decreased | 16.20 | 12.39 | 153 | 55233 | 467904 | 110066009 |
| Hip arthroplasty | 16.18 | 12.39 | 4 | 55382 | 55809 | 110478104 |
| Road traffic accident | 16.10 | 12.39 | 18 | 55368 | 107380 | 110426533 |
| Hypopituitarism | 16.00 | 12.39 | 15 | 55371 | 4375 | 110529538 |
| Drug-induced liver injury | 15.99 | 12.39 | 109 | 55277 | 119958 | 110413955 |
| Haematuria | 15.98 | 12.39 | 83 | 55303 | 82922 | 110450991 |
| Cerebral artery embolism | 15.82 | 12.39 | 11 | 55375 | 2101 | 110531812 |
| Anaemia vitamin B12 deficiency | 15.77 | 12.39 | 9 | 55377 | 1218 | 110532695 |
| Accidental exposure to product | 15.68 | 12.39 | 3 | 55383 | 50005 | 110483908 |
| Immobilisation syndrome | 15.67 | 12.39 | 8 | 55378 | 868 | 110533045 |
| Erectile dysfunction | 15.64 | 12.39 | 31 | 55355 | 18525 | 110515388 |
| Hyperglycaemia | 15.63 | 12.39 | 84 | 55302 | 85006 | 110448907 |
| Periodontitis | 15.63 | 12.39 | 16 | 55370 | 5192 | 110528721 |
| Red blood cell abnormality | 15.56 | 12.39 | 8 | 55378 | 880 | 110533033 |
| Subarachnoid haemorrhage | 15.45 | 12.39 | 41 | 55345 | 29661 | 110504252 |
| Head injury | 15.37 | 12.39 | 52 | 55334 | 42965 | 110490948 |
| Abdominal pain upper | 15.34 | 12.39 | 107 | 55279 | 349004 | 110184909 |
| Inflammation | 15.29 | 12.39 | 156 | 55230 | 193082 | 110340831 |
| Diarrhoea | 15.29 | 12.39 | 707 | 54679 | 1138798 | 109395115 |
| Throat irritation | 15.21 | 12.39 | 4 | 55382 | 53548 | 110480365 |
| Atrioventricular block | 15.21 | 12.39 | 29 | 55357 | 16848 | 110517065 |
| Haemoglobin urine present | 15.20 | 12.39 | 8 | 55378 | 924 | 110532989 |
| Injection site erythema | 14.99 | 12.39 | 15 | 55371 | 94161 | 110439752 |
| Diverticulum intestinal haemorrhagic | 14.97 | 12.39 | 15 | 55371 | 4748 | 110529165 |
| Pulmonary hypertension | 14.92 | 12.39 | 61 | 55325 | 55159 | 110478754 |
| Nasal mucosal erosion | 14.87 | 12.39 | 4 | 55382 | 68 | 110533845 |
| Puncture site infection | 14.87 | 12.39 | 4 | 55382 | 68 | 110533845 |
| Cellulitis | 14.81 | 12.39 | 111 | 55275 | 125905 | 110408008 |
| Psoriatic arthropathy | 14.70 | 12.39 | 157 | 55229 | 196604 | 110337309 |
| Retinal artery occlusion | 14.50 | 12.39 | 14 | 55372 | 4235 | 110529678 |
| Pseudohyponatraemia | 14.46 | 12.39 | 5 | 55381 | 203 | 110533710 |
| Full blood count abnormal | 14.45 | 12.39 | 5 | 55381 | 56047 | 110477866 |
| Stomatitis | 14.39 | 12.39 | 78 | 55308 | 270164 | 110263749 |
| Fibrin D dimer increased | 14.36 | 12.39 | 21 | 55365 | 9824 | 110524089 |
| Subcutaneous haematoma | 14.31 | 12.39 | 12 | 55374 | 3024 | 110530889 |
| Beta 2 microglobulin increased | 14.30 | 12.39 | 7 | 55379 | 694 | 110533219 |
| Hepatic enzyme increased | 14.27 | 12.39 | 98 | 55288 | 320794 | 110213119 |
| Hypozincaemia | 14.26 | 12.39 | 4 | 55382 | 80 | 110533833 |
| Joint stiffness | 14.18 | 12.39 | 8 | 55378 | 67235 | 110466678 |
| Haemorrhagic cerebral infarction | 14.13 | 12.39 | 9 | 55377 | 1486 | 110532427 |
| Psychotic disorder | 14.10 | 12.39 | 4 | 55382 | 50933 | 110482980 |
| Skin erosion | 14.09 | 12.39 | 16 | 55370 | 5838 | 110528075 |
| Ureterolithiasis | 14.09 | 12.39 | 14 | 55372 | 4388 | 110529525 |
| Mesenteric vein thrombosis | 14.03 | 12.39 | 10 | 55376 | 1985 | 110531928 |
| Bradycardia | 14.00 | 12.39 | 129 | 55257 | 155388 | 110378525 |
| Immune-mediated hepatic disorder | 13.96 | 12.39 | 14 | 55372 | 4436 | 110529477 |
| Feeling hot | 13.95 | 12.39 | 15 | 55371 | 91091 | 110442822 |
| Exostosis | 13.91 | 12.39 | 3 | 55383 | 45953 | 110487960 |
| Cognitive disorder | 13.86 | 12.39 | 14 | 55372 | 87497 | 110446416 |
| Chronic lymphocytic leukaemia | 13.83 | 12.39 | 16 | 55370 | 5952 | 110527961 |
| Labelled drug-drug interaction medication error | 13.80 | 12.39 | 39 | 55347 | 29263 | 110504650 |
| Bacterial prostatitis | 13.77 | 12.39 | 4 | 55382 | 91 | 110533822 |
| Renal cyst haemorrhage | 13.76 | 12.39 | 7 | 55379 | 754 | 110533159 |
| Tendon rupture | 13.70 | 12.39 | 25 | 55361 | 14053 | 110519860 |
| Syphilis | 13.64 | 12.39 | 7 | 55379 | 767 | 110533146 |
| Hypertriglyceridaemia | 13.63 | 12.39 | 27 | 55359 | 16127 | 110517786 |
| Gastrointestinal polyp haemorrhage | 13.55 | 12.39 | 7 | 55379 | 778 | 110533135 |
| Injection site swelling | 13.55 | 12.39 | 7 | 55379 | 61783 | 110472130 |
| Hypomagnesaemia | 13.50 | 12.39 | 63 | 55323 | 60307 | 110473606 |
| Hypermagnesaemia | 13.45 | 12.39 | 9 | 55377 | 1614 | 110532299 |
| Brain contusion | 13.43 | 12.39 | 9 | 55377 | 1619 | 110532294 |
| Amnesia | 13.39 | 12.39 | 20 | 55366 | 105388 | 110428525 |
| Anti-neutrophil cytoplasmic antibody positive vasculitis | 13.36 | 12.39 | 15 | 55371 | 5402 | 110528511 |
| Muscle spasms | 13.36 | 12.39 | 83 | 55303 | 278074 | 110255839 |
| Knee arthroplasty | 13.31 | 12.39 | 8 | 55378 | 64940 | 110468973 |
| Dizziness | 13.31 | 12.39 | 258 | 55128 | 697935 | 109835978 |
| Cytomegalovirus test positive | 13.28 | 12.39 | 17 | 55369 | 7019 | 110526894 |
| Cerebral artery thrombosis | 13.23 | 12.39 | 9 | 55377 | 1659 | 110532254 |
| Angina pectoris | 13.19 | 12.39 | 64 | 55322 | 62231 | 110471682 |
| Acute coronary syndrome | 13.15 | 12.39 | 33 | 55353 | 23079 | 110510834 |
| Haemolytic anaemia | 13.11 | 12.39 | 31 | 55355 | 20889 | 110513024 |
| Muscular weakness | 13.07 | 12.39 | 72 | 55314 | 248396 | 110285517 |
| Obstructive pancreatitis | 13.06 | 12.39 | 8 | 55378 | 1233 | 110532680 |
| Urine output decreased | 13.05 | 12.39 | 30 | 55356 | 19846 | 110514067 |
| Renal cyst infection | 13.05 | 12.39 | 5 | 55381 | 273 | 110533640 |
| Drug resistance | 12.95 | 12.39 | 6 | 55380 | 56368 | 110477545 |
| Haematocrit abnormal | 12.92 | 12.39 | 9 | 55377 | 1724 | 110532189 |
| Prothrombin time abnormal | 12.82 | 12.39 | 8 | 55378 | 1274 | 110532639 |
| Ascites | 12.80 | 12.39 | 85 | 55301 | 92723 | 110441190 |
| Colitis ulcerative | 12.69 | 12.39 | 12 | 55374 | 77351 | 110456562 |
| Lethargy | 12.63 | 12.39 | 17 | 55369 | 93559 | 110440354 |
| Gastric ulcer haemorrhage | 12.56 | 12.39 | 20 | 55366 | 10074 | 110523839 |
| Underdose | 12.54 | 12.39 | 64 | 55322 | 63490 | 110470423 |
| Bladder transitional cell carcinoma stage 0 | 12.51 | 12.39 | 4 | 55382 | 127 | 110533786 |
| Dermatophytosis of nail | 12.50 | 12.39 | 5 | 55381 | 306 | 110533607 |
| COVID-19 pneumonia | 12.49 | 12.39 | 44 | 55342 | 37099 | 110496814 |
| Pulmonary congestion | 12.48 | 12.39 | 39 | 55347 | 30927 | 110502986 |
| Troponin increased | 12.47 | 12.39 | 38 | 55348 | 29728 | 110504185 |
| Peripheral arterial occlusive disease | 12.40 | 12.39 | 19 | 55367 | 9261 | 110524652 |
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | M04AA03 | MUSCULO-SKELETAL SYSTEM ANTIGOUT PREPARATIONS ANTIGOUT PREPARATIONS Preparations inhibiting uric acid production |
| FDA MoA | N0000000206 | Xanthine Oxidase Inhibitors |
| MeSH PA | D006074 | Gout Suppressants |
| MeSH PA | D018501 | Antirheumatic Agents |
| FDA EPC | N0000175698 | Xanthine Oxidase Inhibitor |
| CHEBI has role | CHEBI:35554 | cardiovascular drug |
| CHEBI has role | CHEBI:35634 | EC 1.17.3.2 (xanthine oxidase) inhibitor |
| CHEBI has role | CHEBI:35674 | antihypertensive agent |
| CHEBI has role | CHEBI:35845 | gout suppressant |
| CHEBI has role | CHEBI:231911 | renoprotective agent |
Related Drugs by ATC class:
M04AA Preparations inhibiting uric acid production 2 drugs
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Hyperuricemia | indication | 35885006 | DOID:1920 |
| Gout | indication | 90560007 | DOID:13189 |
| Gout Prevention | indication | ||
| Myocardial infarction | contraindication | 22298006 | DOID:5844 |
| Liver function tests abnormal | contraindication | 166603001 | |
| Cerebrovascular accident | contraindication | 230690007 | |
| Thromboembolic disorder | contraindication | 371039008 |
🐶 Veterinary Drug Use
None
🐶 Veterinary products
None
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 3.3 | acidic |
| pKa2 | 0.46 | Basic |
Orange Book patent data (new drug applications)
| Formulation strength | Trade name | Applicant | Application number | Approval date | Type | Dose form | Route | Patent number | Patent expiration date | Patent use |
|---|---|---|---|---|---|---|---|---|---|---|
| 40MG | ULORIC | TAKEDA PHARMS USA | N021856 | Feb. 13, 2009 | RX | TABLET | ORAL | 8372872 | Sept. 8, 2031 | USE OF FEBUXOSTAT FOR THE MANAGEMENT OF HYPERURICEMIA IN PATIENTS SUFFERING FROM GOUT AND, WHEN USED WITH THEOPHYLLINE WITHOUT THE NEED FOR DOSE ADJUSTMENT OF THEOPHYLLINE |
| 40MG | ULORIC | TAKEDA PHARMS USA | N021856 | Feb. 13, 2009 | RX | TABLET | ORAL | 9107912 | Sept. 8, 2031 | USE OF FEBUXOSTAT FOR THE MANAGEMENT OF HYPERURICEMIA IN PATIENTS SUFFERING FROM GOUT AND, WHEN USED WITH THEOPHYLLINE WITHOUT THE NEED FOR DOSE ADJUSTMENT OF THEOPHYLLINE |
| 80MG | ULORIC | TAKEDA PHARMS USA | N021856 | Feb. 13, 2009 | RX | TABLET | ORAL | 8372872 | Sept. 8, 2031 | USE OF FEBUXOSTAT FOR THE MANAGEMENT OF HYPERURICEMIA IN PATIENTS SUFFERING FROM GOUT AND, WHEN USED WITH THEOPHYLLINE WITHOUT THE NEED FOR DOSE ADJUSTMENT OF THEOPHYLLINE |
| 80MG | ULORIC | TAKEDA PHARMS USA | N021856 | Feb. 13, 2009 | RX | TABLET | ORAL | 9107912 | Sept. 8, 2031 | USE OF FEBUXOSTAT FOR THE MANAGEMENT OF HYPERURICEMIA IN PATIENTS SUFFERING FROM GOUT AND, WHEN USED WITH THEOPHYLLINE WITHOUT THE NEED FOR DOSE ADJUSTMENT OF THEOPHYLLINE |
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Xanthine dehydrogenase/oxidase | Enzyme | INHIBITOR | Ki | 9.22 | WOMBAT-PK | CHEMBL | |||
| ATP-binding cassette sub-family G member 2 | Transporter | IC50 | 7.57 | CHEMBL | |||||
| Flavin reductase (NADPH) | Enzyme | Kd | 5.79 | CHEMBL | |||||
| Histone deacetylase 6 | Enzyme | IC50 | 7.26 | CHEMBL | |||||
| Potassium voltage-gated channel subfamily H member 2 | Ion channel | EC50 | 7.44 | WOMBAT-PK | |||||
| RISC-loading complex subunit TARBP2 | Cytosolic other | EC50 | 7.04 | CHEMBL | |||||
| Xanthine dehydrogenase/oxidase | Enzyme | IC50 | 8.52 | CHEMBL | |||||
| Xanthine dehydrogenase/oxidase | Enzyme | IC50 | 8.40 | CHEMBL |
External reference:
| ID | Source |
|---|---|
| 4025245 | VUID |
| N0000179385 | NUI |
| D01206 | KEGG_DRUG |
| 4025245 | VANDF |
| C0249529 | UMLSCUI |
| CHEBI:31596 | CHEBI |
| TEI | PDB_CHEM_ID |
| CHEMBL1164729 | ChEMBL_ID |
| DB04854 | DRUGBANK_ID |
| D000069465 | MESH_DESCRIPTOR_UI |
| 134018 | PUBCHEM_CID |
| 6817 | IUPHAR_LIGAND_ID |
| 8140 | INN_ID |
| 101V0R1N2E | UNII |
| 73689 | RXNORM |
| 161190 | MMSL |
| 232999 | MMSL |
| 26212 | MMSL |
| d07397 | MMSL |
| 012966 | NDDF |
| 441610003 | SNOMEDCT_US |
| 441743008 | SNOMEDCT_US |
| 101V0R1N2E | INXIGHT DRUGS |
Pharmaceutical products:
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0054-0413 | TABLET | 40 mg | ORAL | ANDA | 27 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0054-0414 | TABLET | 80 mg | ORAL | ANDA | 27 sections |
| FEBUXOSTAT | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0527-2244 | TABLET | 40 mg | ORAL | ANDA | 31 sections |
| FEBUXOSTAT | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0527-2248 | TABLET | 80 mg | ORAL | ANDA | 31 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 0904-7395 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 26 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 0904-7396 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 26 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7484 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 26 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7484 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 26 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7485 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 26 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 0904-7485 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 26 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 14445-156 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 27 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 14445-157 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 27 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 16714-059 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 30 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 16714-060 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 30 sections |
| ULORIC | HUMAN PRESCRIPTION DRUG LABEL | 1 | 21695-516 | TABLET | 80 mg | ORAL | NDA | 29 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 27808-206 | TABLET | 40 mg | ORAL | ANDA | 31 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 27808-207 | TABLET | 80 mg | ORAL | ANDA | 31 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 33342-274 | FILM | 40 mg | ORAL | ANDA | 27 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 33342-275 | FILM | 80 mg | ORAL | ANDA | 27 sections |
| ULORIC | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43353-305 | TABLET | 40 mg | ORAL | NDA | 29 sections |
| FEBUXOSTAT | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43547-295 | TABLET | 40 mg | ORAL | ANDA | 28 sections |
| FEBUXOSTAT | HUMAN PRESCRIPTION DRUG LABEL | 1 | 43547-296 | TABLET | 80 mg | ORAL | ANDA | 28 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 46708-190 | TABLET, COATED | 40 mg | ORAL | ANDA | 29 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 46708-191 | TABLET, COATED | 80 mg | ORAL | ANDA | 29 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 47335-721 | TABLET, FILM COATED | 40 mg | ORAL | ANDA | 30 sections |
| Febuxostat | Human Prescription Drug Label | 1 | 47335-722 | TABLET, FILM COATED | 80 mg | ORAL | ANDA | 30 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-293 | TABLET | 40 mg | ORAL | ANDA | 27 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 51407-294 | TABLET | 80 mg | ORAL | ANDA | 27 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 55111-796 | TABLET | 40 mg | ORAL | ANDA | 29 sections |
| Febuxostat | HUMAN PRESCRIPTION DRUG LABEL | 1 | 55111-797 | TABLET | 80 mg | ORAL | ANDA | 29 sections |